Newbury Pharmaceuticals AB (publ)
Stockholm Stock Exchange NEWBRY.ST
Newbury Pharmaceuticals AB (publ) Market Capitalization on January 13, 2025: USD 7.30 M
Newbury Pharmaceuticals AB (publ) Market Capitalization is USD 7.30 M on January 13, 2025, a -12.00% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
-
Newbury Pharmaceuticals AB (publ) 52-week high Market Capitalization is USD 9.08 M on October 29, 2024, which is 24.43% above the current Market Capitalization.
-
Newbury Pharmaceuticals AB (publ) 52-week low Market Capitalization is USD 6.29 M on September 11, 2024, which is -13.83% below the current Market Capitalization.
-
Newbury Pharmaceuticals AB (publ) average Market Capitalization for the last 52 weeks is USD 7.63 M.
Key data
| Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
|---|
Market news
Loading...
Stockholm Stock Exchange: NEWBRY.ST
| CEO | Mr. Lars Minor |
| IPO Date | Feb. 4, 2022 |
| Location | Sweden |
| Headquarters | Scheeletorget 1 |
| Employees | 6 |
| Sector | Health Care |
| Industries | |
Description
Newbury Pharmaceuticals AB (publ) operates as hybrid pharmaceutical company in Sweden, and Scandinavian market. It offers oncology, rare diseases, neurology, and other treatment products. The company was incorporated in 2020 and is based in Lund, Sweden.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email